Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Zn-S10 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Zn-S10

Approved

STANDARD

Zn-S10

Lloyd Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 16d7b592d5e3dc2d
Company: Lloyd Laboratories, Inc.
Type: Standard

Approval Details

Approval Id: 16d7b592d5e3dc2d
Drug Approval Philippines Name: Zn-S10
Product Name: Zn-S10
Registration Number: DRP-9760
Brand Name: Zn-S10
Generic Name: Zinc
Dosage Form: Film-Coated
Dosage Strength: 10 mg (equivalent to 27.5 mg Zinc Sulfate Monohydrate)
Manufacturer: Lloyd Laboratories, Inc.
Trader: Eadrix Pharmaceuticals Phils., Inc.
Issuance Date: 28 May 2021
Expiry Date: 28 May 2026
Classification: Over-the-counter (OTC) Drug

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

16d7b592d5e3dc2d

Type

Standard

Back to Philippines FDA Approvals